Person
Alex Gorsky
1 episodes · 8 quoted claims
Alex Gorsky says Johnson & Johnson's vaccine manufacturing builds on a technology called PER.C6, developed more than a decade earlier.
“And more than a decade ago, there was a technology called Percy6 that utilized a different kind of protein and biology in the production of vaccines.”
Conversations with Mike Milken · 0:15:32
Alex Gorsky said Johnson & Johnson expected to provide hundreds of millions of vaccine doses in the first half of 2021 if its trials succeeded.
“now we're in a position where we feel confident that in the first half of 2021, we should be able to provide hundreds of millions of doses.”
Conversations with Mike Milken · 0:16:01
Alex Gorsky says earlier experience with SARS and Zika did not progress as far as the COVID-19 vaccine effort.
“We had had experiences with SARS and Zika that didn't go in near the direction that we've seen here.”
Conversations with Mike Milken · 0:08:54
Alex Gorsky says Johnson & Johnson's earliest COVID-19 interest centered on its antiviral drugs before turning to a vector-based vaccine.
“And the early interest within Janssen and Johnson & Johnson was more around our antiviral portfolio.”
Conversations with Mike Milken · 0:08:54
Alex Gorsky says Pfizer and Moderna use an mRNA approach while Johnson & Johnson uses a vector approach.
“We know Pfizer and Moderna has taken an mRNA approach, we're utilizing a vector approach.”
Conversations with Mike Milken · 0:20:40
Alex Gorsky says research heads at Johnson & Johnson and Pfizer joined regular joint calls with US health leaders during the pandemic.
“Paul Stoffels, our head of research and development, is talking to Mikhail Dolstein, who's heading R &D for Pfizer, where they're on a joint phone call on Saturday morning”
Conversations with Mike Milken · 0:12:47
Alex Gorsky says vaccinating about seven billion people would be unprecedented in world history.
“One of the issues we've been looking at is the distribution reaching 7 billion people. We've never done that in the world's history.”
Conversations with Mike Milken · 0:21:18
Alex Gorsky says global vaccine access efforts involved developed countries along with Gavi, CEPI and the Bill and Melinda Gates Foundation.
“We're seeing good collaboration among the developed countries, but also with Gavi, with CEPI, with the Bill and Melinda Gates Foundation and others”
Conversations with Mike Milken · 0:22:11